Guangzhou Baiy | 600332 - Ebitda


Guangzhou Baiy reported CNY2.31B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 2.65B 3.41B Jun/2026
Cipla INR 14.03B 4.48B Jun/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Jiangsu Hengrui CNY 2.56B 259.7M Mar/2026
Kalbe Farma IDR 1.44T 141.07B Mar/2026
Richter Gedeon HUF 83.47B 692M Mar/2026
Sh Fosun Pharma CNY 1.65B 88.09M Mar/2026
Sh Pharmaceutical CNY 2.77B 2.24B Mar/2026
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026